HT Vista Managing Director Liron Levy-Hirsch pictured with previous winners of a recent congress giveaway
HT Vista Offers Exclusive Discounts And Giveaways At BVA Live 2025
HT Vista, the veterinary imaging company behind the world’s first non-invasive, AI-powered cancer screening device for dogs, will be exhibiting at BVA Live 2025. The team will be showcasing the latest software upgrades, demonstrating the device’s enhanced diagnostic capabilities and offering exclusive event-only savings to delegates attending the show.
Delegates visiting Stand J45 can take advantage of a 50% discount on device purchases made during the show. In addition, anyone using the voucher included in the BVA Live voucher booklet can enter a prize draw to win a free one-year subscription to HT Vista, worth over £2,000.
Throughout the event, HT Vista’s Managing Director Liron Levy-Hirsch and Customer Success Manager Olivia Morton will be available for live demonstrations and to answer questions about the device, training and implementation. The team will also be showcasing the HT Vista Academy, a dedicated education platform that supports veterinary professionals in confidently integrating the technology into everyday practice.
Liron says, “It will be great to be back at BVA Live and I’m looking forward to showcasing the new and improved HT Vista. Our new diagnostic feature is already helping many vets in practice and their patients, and I’m excited to introduce the new capabilities to delegates.”
Developed to support earlier detection of subcutaneous and dermal tumours in dogs, the HT Vista device combines Heat Diffusion Imaging with advanced artificial intelligence to provide real-time screening results, at point-of-care in practice. A recently launched new diagnostic feature now enables the HT Vista to categorise cancer risk levels of low, moderate and high, and can provide alerts for certain types of masses.
HT Vista’s innovative approach is already transforming how practices manage suspicious skin masses in dogs, reducing delays in diagnosis, generating new income streams and improving client satisfaction.
Visit Stand J45 at BVA Live to learn more, try the device in person and speak to the team about how HT Vista could benefit your practice both clinically and commercially.
More from HT Vista
- HT Vista launches free academy to support users following the launch of their new diagnostic technology
- HT Vista launches new product update with diagnostic capability for lumps on dogs
- Continuous Improvement for HT Vista Canine Cancer Screening Tool
- HT Vet announces distribution partnership with Victor Medical Company
- HT Vet is excited to announce Covetrus as a U.S. National Distributor of HT Vista cancer screening tool